SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Summary of the best evidence for non-pharmaceutical interventions for mild cognitive impairment in Parkinson's disease.

Front Neurol · 2025-07-03

DOI: 10.3389/fneur.2025.1598974PMID: 40677685

Open accessSystematic Review; systematic-review; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

ObjectiveThis study aimed to synthesize and evaluate the best evidence for non-pharmacological interventions targeting mild cognitive impairment in Parkinson's disease (PD-MCI), thereby informing the development of cognitive management strategies for this population.MethodsA systematic search was conducted across multiple databases (e.g., UpToDate, BMJ Best Practice, and Cochrane Library) up to November 2024. Two researchers independently screened literature, assessed quality using standardized tools (AGREE II, JBI criteria), and graded evidence.ResultsThirteen studies were included (five guidelines, two clinical decisions, two systematic reviews, one meta-analysis, and three RCTs). Twenty evidence points were categorized into six themes: safety/efficacy, assessment, cognitive training, exercise, health education, and multi-strategy approaches.ConclusionThis study consolidates evidence supporting non-pharmacological interventions for PD-MCI, offering actionable recommendations for clinical practice to delay progression to Parkinson's disease dementia (PDD).

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.